2014
DOI: 10.1128/aac.03622-14
|View full text |Cite
|
Sign up to set email alerts
|

PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

Abstract: Ceftaroline is the first member of a novel class of cephalosporins approved for use in the United States. Although prior studies have identified eight ceftaroline-resistant methicillin-resistant Staphylococcus aureus (MRSA) isolates in Europe and Asia with MICs ranging from 4 to 8 mg/liter, high-level resistance to ceftaroline (>32 mg/liter) has not been described in MRSA strains isolated in the United States. We isolated a ceftaroline-resistant (MIC > 32 mg/liter) MRSA strain from the blood of a cystic fibros… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

4
109
0
2

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 123 publications
(115 citation statements)
references
References 33 publications
4
109
0
2
Order By: Relevance
“…It has been used to identify unknown organisms, discover new mechanisms of antimicrobial resistance, and understand the virulence of isolates of uncertain taxonomic status (5,24). Whole-genome sequencing of microbes was previously validated in our molecular diagnostics laboratory, and it is run once per week as a routine clinical test.…”
Section: Discussionmentioning
confidence: 99%
“…It has been used to identify unknown organisms, discover new mechanisms of antimicrobial resistance, and understand the virulence of isolates of uncertain taxonomic status (5,24). Whole-genome sequencing of microbes was previously validated in our molecular diagnostics laboratory, and it is run once per week as a routine clinical test.…”
Section: Discussionmentioning
confidence: 99%
“…It is present in ceftobiprole-passaged COL (among other mutations) (11), it is the only mecA mutation in the ceftaroline-passaged SF8300, and it has been reported in clinical isolates (17,18). Structurally, E447 resides in the penicillin-binding domain of PBP2a and interacts with the R2 group of ceftobiprole and other ␤-lactams (3, 19).…”
mentioning
confidence: 99%
“…The major area of differentiation from other ␤-lactam drugs is the activity of ceftaroline (the active metabolite of ceftaroline fosamil) against MRSA, which is the result of improved affinity against the alternative penicillin-binding protein PBP2a (or MecA) that is also horizontally acquired on other SCCmec cassettes. However, substitutions in MecA have been linked to decreased susceptibility to ceftaroline, although those present in the non-penicillin-binding domain (nPBD) have less effect than those in the transpeptidase active site in the penicillin-binding domain (PBD) (6)(7)(8)(9)(10). During the genetic characterization of MRSA isolates collected during a 2012 surveillance program, a MRSA isolate (TRN6234) that contained a MecC protein identical to the protein encoded by LA-MRSA isolate LGA251 was identified from a patient in a German hospital with a serious wound infection (1).…”
mentioning
confidence: 99%
“…The only other difference is the relatively conservative hydrophobic Y 446 F substitution. In MecA, this Y446 residue has been implicated in high-level resistance to ceftaroline, albeit as a polar Y 446 N substitution (8). This suggests that despite the high level of identity between the PBDs of these two alternative penicillin-binding proteins, subtle conformational differences which impact the binding mode of ceftaroline likely exist, and we await a cocomplex structure to interpret the differences.…”
mentioning
confidence: 99%
See 1 more Smart Citation